{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T09:23:34Z","timestamp":1787390614164,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100023674","name":"Deanship of Scientific Research, King Khalid University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100023674","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-026-04154-z","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T08:36:05Z","timestamp":1787387765000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Global landscape and thematic evolution of glaucoma pharmacotherapy research (1996\u20132025): A bibliometric and science mapping analysis"],"prefix":"10.1007","volume":"46","author":[{"given":"Azfar Athar","family":"Ishaqui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad Ali","family":"Alsaleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asaad Ahmed Asaad","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Ali","family":"Kaddoura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Orayj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayah","family":"Asiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sultan M.","family":"Alshahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman Ashfaq","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narendar","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Bilal","family":"Maqsood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,22]]},"reference":[{"issue":"3","key":"4154_CR1","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/bjo.2005.081224","volume":"90","author":"HA Quigley","year":"2006","unstructured":"Quigley HA, Broman AT (2006) The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90(3):262\u2013267","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"4154_CR2","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","volume":"121","author":"Y-C Tham","year":"2014","unstructured":"Tham Y-C, Li X, Wong TY, Quigley HA, Aung T, Cheng C-Y (2014) Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 121(11):2081\u20132090","journal-title":"Ophthalmology"},{"issue":"9422","key":"4154_CR3","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/S0140-6736(04)16257-0","volume":"363","author":"RN Weinreb","year":"2004","unstructured":"Weinreb RN, Khaw PT (2004) Primary open-angle glaucoma. Lancet 363(9422):1711\u20131720","journal-title":"Lancet"},{"issue":"6","key":"4154_CR4","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1001\/archopht.120.6.701","volume":"120","author":"MA Kass","year":"2002","unstructured":"Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP et al (2002) The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120(6):701\u2013713","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"4154_CR5","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","volume":"120","author":"A Heijl","year":"2002","unstructured":"Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M et al (2002) Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 120(10):1268\u20131279","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"4154_CR6","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.ophtha.2004.12.035","volume":"112","author":"CM Olthoff","year":"2005","unstructured":"Olthoff CM, Schouten JS, van de Borne BW, Webers CA (2005) Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension: an evidence-based review. Ophthalmology 112(6):953","journal-title":"Ophthalmology"},{"issue":"4","key":"4154_CR7","doi-asserted-by":"publisher","first-page":"598. e1","DOI":"10.1016\/j.ajo.2005.04.051","volume":"140","author":"BL Nordstrom","year":"2005","unstructured":"Nordstrom BL, Friedman DS, Mozaffari E, Quigley HA, Walker AM (2005) Persistence and adherence with topical glaucoma therapy. Am J Ophthalmol 140(4):598. e1","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"4154_CR8","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1016\/S0161-6420(96)30407-7","volume":"103","author":"CB Camras","year":"1996","unstructured":"Camras CB, Alm A, Watson P, Stjernschantz J, Aasved H, Jangard P et al (1996) Latanoprost, a prostaglandin analog, for glaucoma therapy: efficacy and safety after 1 year of treatment in 198 patients. Ophthalmology 103(11):1916\u20131924","journal-title":"Ophthalmology"},{"issue":"6","key":"4154_CR9","doi-asserted-by":"publisher","first-page":"S107","DOI":"10.1016\/j.survophthal.2008.08.010","volume":"53","author":"CB Toris","year":"2008","unstructured":"Toris CB, B\u2019Ann TG, Kaufman PL (2008) Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction. Surv Ophthalmol 53(6):S107\u2013S120","journal-title":"Surv Ophthalmol"},{"key":"4154_CR10","doi-asserted-by":"crossref","unstructured":"Parrish RK, Palmberg P, Sheu W-P, Group XS (2003) A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: A 12-week, randomized, masked-evaluator multicenter study. American journal of ophthalmology. 135(5):688\u2013703","DOI":"10.1016\/S0002-9394(03)00098-9"},{"key":"4154_CR11","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1319628","author":"WG El Hajj Moussa","year":"2018","unstructured":"El Hajj Moussa WG, Farhat RG, Nehme JC, Sahyoun MA, Schakal AR, Jalkh AE et al (2018) Comparison of efficacy and ocular surface disease index score between bimatoprost, latanoprost, travoprost, and tafluprost in glaucoma patients. J Ophthalmol. https:\/\/doi.org\/10.1155\/2018\/1319628","journal-title":"J Ophthalmol"},{"issue":"6","key":"4154_CR12","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1097\/ICO.0b013e3181c325b2","volume":"29","author":"RD Fechtner","year":"2010","unstructured":"Fechtner RD, Godfrey DG, Budenz D, Stewart JA, Stewart WC, Jasek MC (2010) Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications. Cornea 29(6):618\u2013621","journal-title":"Cornea"},{"issue":"2","key":"4154_CR13","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","volume":"84","author":"N Van Eck","year":"2010","unstructured":"Van Eck N, Waltman L (2010) Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics 84(2):523\u2013538","journal-title":"Scientometrics"},{"issue":"1","key":"4154_CR14","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s11192-006-0144-7","volume":"69","author":"L Egghe","year":"2006","unstructured":"Egghe L (2006) Theory and practise of the g-index. Scientometrics 69(1):131\u2013152. https:\/\/doi.org\/10.1007\/s11192-006-0144-7","journal-title":"Scientometrics"},{"issue":"46","key":"4154_CR15","doi-asserted-by":"publisher","first-page":"16569","DOI":"10.1073\/pnas.0507655102","volume":"102","author":"JE Hirsch","year":"2005","unstructured":"Hirsch JE (2005) An index to quantify an individual\u2019s scientific research output. Proc Natl Acad Sci U S A 102(46):16569\u201316572","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4154_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1108\/00220410810844150","volume":"64","author":"L Bornmann","year":"2008","unstructured":"Bornmann L, Daniel HD (2008) What do citation counts measure? A review of studies on citing behavior. J Doc 64(1):45\u201380","journal-title":"J Doc"},{"issue":"9774","key":"4154_CR17","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/S0140-6736(10)61423-7","volume":"377","author":"HA Quigley","year":"2011","unstructured":"Quigley HA (2011) Glaucoma. Lancet 377(9774):1367\u20131377. https:\/\/doi.org\/10.1016\/S0140-6736(10)61423-7","journal-title":"Lancet"},{"issue":"6","key":"4154_CR18","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1001\/archopht.120.6.714","volume":"120","author":"MO Gordon","year":"2002","unstructured":"Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA et al (2002) The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 120(6):714\u2013720","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"4154_CR19","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S0161-6420(96)30749-5","volume":"103","author":"Camras CB, Group USLS","year":"1996","unstructured":"Camras CB, Group USLS (1996) Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month, masked, multicenter trial in the United States. Ophthalmology 103(1):138\u2013147","journal-title":"Ophthalmology"},{"issue":"9975","key":"4154_CR20","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/S0140-6736(14)62111-5","volume":"385","author":"DF Garway-Heath","year":"2015","unstructured":"Garway-Heath DF, Crabb DP, Bunce C, Lascaratos G, Amalfitano F, Anand N et al (2015) Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial. The Lancet 385(9975):1295\u20131304","journal-title":"The Lancet"},{"issue":"5","key":"4154_CR21","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1001\/jamaophthalmol.2021.0341","volume":"139","author":"MA Kass","year":"2021","unstructured":"Kass MA, Heuer DK, Higginbotham EJ, Parrish RK, Khanna CL, Brandt JD et al (2021) Assessment of cumulative incidence and severity of primary open-angle glaucoma among participants in the ocular hypertension treatment study after 20 years of follow-up. JAMA ophthalmol 139(5):558\u2013566","journal-title":"JAMA ophthalmol"},{"issue":"2","key":"4154_CR22","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S1388-1981(99)00164-X","volume":"1483","author":"M Abramovitz","year":"2000","unstructured":"Abramovitz M, Adam M, Boie Y, Carri\u00e8re M-C, Denis D, Godbout C et al (2000) The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochimica et Biophysica Acta (BBA)-Molecular Cell Biology Lipids 1483(2):285\u2013293","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Cell Biology Lipids"},{"issue":"3","key":"4154_CR23","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/sj.bjp.0706048","volume":"144","author":"JG Baker","year":"2005","unstructured":"Baker JG (2005) The selectivity of \u03b2-adrenoceptor antagonists at the human \u03b21, \u03b22 and \u03b23 adrenoceptors. Br J Pharmacol 144(3):317\u2013322","journal-title":"Br J Pharmacol"},{"issue":"1","key":"4154_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0163-7258(96)00198-2","volume":"74","author":"S Lindskog","year":"1997","unstructured":"Lindskog S (1997) Structure and mechanism of carbonic anhydrase. Pharmacol Ther 74(1):1\u201320","journal-title":"Pharmacol Ther"},{"issue":"5","key":"4154_CR25","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1517\/13543776.10.5.575","volume":"10","author":"CT Supuran","year":"2000","unstructured":"Supuran CT, Scozzafava A (2000) Carbonic anhydrase inhibitors and their therapeutic potential. Expert Opin Ther Pat 10(5):575\u2013600","journal-title":"Expert Opin Ther Pat"},{"issue":"4","key":"4154_CR26","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1136\/bjo.86.4.418","volume":"86","author":"P Pisella","year":"2002","unstructured":"Pisella P, Pouliquen P, Baudouin C (2002) Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. Br J Ophthalmol 86(4):418\u2013423","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"4154_CR27","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","volume":"29","author":"C Baudouin","year":"2010","unstructured":"Baudouin C, Labb\u00e9 A, Liang H, Pauly A, Brignole-Baudouin F (2010) Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res 29(4):312\u2013334","journal-title":"Prog Retin Eye Res"},{"issue":"6","key":"4154_CR28","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/S0149-2918(99)80026-5","volume":"21","author":"KC Farmer","year":"1999","unstructured":"Farmer KC (1999) Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 21(6):1074\u20131090","journal-title":"Clin Ther"},{"issue":"9","key":"4154_CR29","first-page":"728","volume":"15","author":"J Yeaw","year":"2009","unstructured":"Yeaw J, Benner JS, Walt JG, Sian S, Smith DB (2009) Comparing adherence and persistence across 6 chronic medication classes. J Manag Care Pharm 15(9):728\u2013740","journal-title":"J Manag Care Pharm"},{"key":"4154_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ajo.2025.03.025","volume":"275","author":"C Baudouin","year":"2025","unstructured":"Baudouin C, Myers JS, Van Tassel SH, Goyal NA, Martinez-De-La-Casa J, Ng A et al (2025) Adherence and persistence on prostaglandin analogues for glaucoma: A systematic review and Meta-Analysis. Am J Ophthalmol 275:99\u2013113","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"4154_CR31","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1016\/j.ophtha.2015.06.039","volume":"122","author":"PA Newman-Casey","year":"2015","unstructured":"Newman-Casey PA, Blachley T, Lee PP, Heisler M, Farris KB, Stein JD (2015) Patterns of glaucoma medication adherence over four years of follow-up. Ophthalmology 122(10):2010\u20132021","journal-title":"Ophthalmology"},{"issue":"2","key":"4154_CR32","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41433-021-01668-x","volume":"36","author":"MH Goldstein","year":"2022","unstructured":"Goldstein MH, Silva FQ, Blender N, Tran T, Vantipalli S (2022) Ocular benzalkonium chloride exposure: problems and solutions. Eye 36(2):361\u2013368","journal-title":"Eye"},{"issue":"11","key":"4154_CR33","first-page":"1512","volume":"104","author":"A Hedengran","year":"2020","unstructured":"Hedengran A, Steensberg AT, Virgili G, Azuara-Blanco A, Kolko M (2020) Efficacy and safety evaluation of benzalkonium chloride preserved eye-drops compared with alternatively preserved and preservative-free eye-drops in the treatment of glaucoma: a systematic review and meta-analysis. Br J Ophthalmol 104(11):1512\u20131518","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"4154_CR34","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s40135-019-00210-3","volume":"7","author":"CE Capitena Young","year":"2019","unstructured":"Capitena Young CE, Kahook MY, Seibold LK (2019) Novel drug delivery systems for the treatment of glaucoma. Curr Ophthalmol Rep 7(2):143\u2013149","journal-title":"Curr Ophthalmol Rep"},{"issue":"3","key":"4154_CR35","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s40265-018-0877-7","volume":"78","author":"SM Hoy","year":"2018","unstructured":"Hoy SM (2018) Netarsudil ophthalmic solution 0.02%: first global approval. Drugs 78(3):389\u2013396","journal-title":"Drugs"},{"issue":"6","key":"4154_CR36","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s40266-020-00769-8","volume":"37","author":"M Shirley","year":"2020","unstructured":"Shirley M (2020) Bimatoprost Implant: First Approval: M. Shirley Drugs Aging 37(6):457\u2013462","journal-title":"Shirley Drugs Aging"},{"issue":"4","key":"4154_CR37","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3390\/ph18040523","volume":"18","author":"JK Tan","year":"2025","unstructured":"Tan JK, Khaw PT, Henein C (2025) Rho kinase (ROCK) inhibitors in the treatment of glaucoma and glaucoma surgery: a systematic review of early to late phase clinical trials. Pharmaceuticals (Basel) 18(4):523","journal-title":"Pharmaceuticals (Basel)"},{"key":"4154_CR38","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ajo.2025.06.037","volume":"278","author":"BK Tao","year":"2025","unstructured":"Tao BK, Dhivagaran T, Butt F, Popovic M, Margolin EA, Kohly RP (2025) Industry sponsorship and research outcomes in a sample of landmark ophthalmology trials. Am J Ophthalmol 278:266\u2013270","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"4154_CR39","doi-asserted-by":"publisher","first-page":"e0268433","DOI":"10.1371\/journal.pone.0268433","volume":"17","author":"JL Nelis","year":"2022","unstructured":"Nelis JL, Rosas da Silva G, Ortu\u00f1o J, Tsagkaris AS, Borremans B, Haslova J et al (2022) The general growth tendency: a tool to improve publication trend reporting by removing record inflation bias and enabling quantitative trend analysis. PLoS ONE 17(5):e0268433","journal-title":"PLoS ONE"},{"issue":"4","key":"4154_CR40","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.joi.2008.07.003","volume":"2","author":"L Leydesdorff","year":"2008","unstructured":"Leydesdorff L, Wagner CS (2008) International collaboration in science and the formation of a core group. J Informetr 2(4):317\u2013325","journal-title":"J Informetr"},{"issue":"4","key":"4154_CR41","doi-asserted-by":"publisher","first-page":"101565","DOI":"10.1016\/j.joi.2024.101565","volume":"18","author":"J Wang","year":"2024","unstructured":"Wang J, Frietsch R, Neuh\u00e4usler P, Hooi R (2024) International collaboration leading to high citations: global impact or home country effect? J Informetr 18(4):101565","journal-title":"J Informetr"},{"issue":"9","key":"4154_CR42","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.3390\/ph18091422","volume":"18","author":"A Radu","year":"2025","unstructured":"Radu A, Radu A-F, Bungau GS, Tit DM, Negru PA (2025) Tracing five decades of psoriasis pharmacotherapy: a large-scale bibliometric investigation with AI-guided terminology normalization. Pharmaceuticals (Basel) 18(9):1422","journal-title":"Pharmaceuticals (Basel)"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-026-04154-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-026-04154-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-026-04154-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T08:36:06Z","timestamp":1787387766000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-026-04154-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,22]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4154"],"URL":"https:\/\/doi.org\/10.1007\/s10792-026-04154-z","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,22]]},"assertion":[{"value":"27 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have agreed to the publication of this study.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"341"}}